Report Detail

Automobile & Transportation Global Automation in Biopharmaceutical Market Insights, Forecast to 2025

  • RnM3517894
  • |
  • 12 June, 2019
  • |
  • Global
  • |
  • 111 pages
  • |
  • QYResearch
  • |
  • Automobile & Transportation

Global Automation in Biopharmaceutical Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Automation in Biopharmaceutical Product
    • 1.2 Key Market Segments in This Study
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Automation in Biopharmaceutical Market Size Growth Rate by Type
      • 1.4.2 Clinical stage automation
      • 1.4.3 Drug discovery stage automation
    • 1.5 Market by Application
      • 1.5.1 Global Automation in Biopharmaceutical Market Size Growth Rate by Application
      • 1.5.2 Research and Development
      • 1.5.3 Clinical
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Automation in Biopharmaceutical Market Size
      • 2.1.1 Global Automation in Biopharmaceutical Revenue 2014-2025
      • 2.1.2 Global Automation in Biopharmaceutical Production 2014-2025
    • 2.2 Automation in Biopharmaceutical Growth Rate (CAGR) 2019-2025
    • 2.3 Analysis of Competitive Landscape
      • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
      • 2.3.2 Key Automation in Biopharmaceutical Manufacturers
        • 2.3.2.1 Automation in Biopharmaceutical Manufacturing Base Distribution, Headquarters
        • 2.3.2.2 Manufacturers Automation in Biopharmaceutical Product Offered
        • 2.3.2.3 Date of Manufacturers Enter into Automation in Biopharmaceutical Market
    • 2.4 Key Trends for Automation in Biopharmaceutical Markets & Products

    3 Market Size by Manufacturers

    • 3.1 Automation in Biopharmaceutical Production by Manufacturers
      • 3.1.1 Automation in Biopharmaceutical Production by Manufacturers
      • 3.1.2 Automation in Biopharmaceutical Production Market Share by Manufacturers
    • 3.2 Automation in Biopharmaceutical Revenue by Manufacturers
      • 3.2.1 Automation in Biopharmaceutical Revenue by Manufacturers (2014-2019)
      • 3.2.2 Automation in Biopharmaceutical Revenue Share by Manufacturers (2014-2019)
    • 3.3 Automation in Biopharmaceutical Price by Manufacturers
    • 3.4 Mergers & Acquisitions, Expansion Plans

    4 Automation in Biopharmaceutical Production by Regions

    • 4.1 Global Automation in Biopharmaceutical Production by Regions
      • 4.1.1 Global Automation in Biopharmaceutical Production Market Share by Regions
      • 4.1.2 Global Automation in Biopharmaceutical Revenue Market Share by Regions
    • 4.2 United States
      • 4.2.1 United States Automation in Biopharmaceutical Production
      • 4.2.2 United States Automation in Biopharmaceutical Revenue
      • 4.2.3 Key Players in United States
      • 4.2.4 United States Automation in Biopharmaceutical Import & Export
    • 4.3 Europe
      • 4.3.1 Europe Automation in Biopharmaceutical Production
      • 4.3.2 Europe Automation in Biopharmaceutical Revenue
      • 4.3.3 Key Players in Europe
      • 4.3.4 Europe Automation in Biopharmaceutical Import & Export
    • 4.4 China
      • 4.4.1 China Automation in Biopharmaceutical Production
      • 4.4.2 China Automation in Biopharmaceutical Revenue
      • 4.4.3 Key Players in China
      • 4.4.4 China Automation in Biopharmaceutical Import & Export
    • 4.5 Japan
      • 4.5.1 Japan Automation in Biopharmaceutical Production
      • 4.5.2 Japan Automation in Biopharmaceutical Revenue
      • 4.5.3 Key Players in Japan
      • 4.5.4 Japan Automation in Biopharmaceutical Import & Export
    • 4.6 South Korea
      • 4.6.1 South Korea Automation in Biopharmaceutical Production
      • 4.6.2 South Korea Automation in Biopharmaceutical Revenue
      • 4.6.3 Key Players in South Korea
      • 4.6.4 South Korea Automation in Biopharmaceutical Import & Export
    • 4.7 India
      • 4.7.1 India Automation in Biopharmaceutical Production
      • 4.7.2 India Automation in Biopharmaceutical Revenue
      • 4.7.3 Key Players in India
      • 4.7.4 India Automation in Biopharmaceutical Import & Export
    • 4.8 Other Regions

    5 Automation in Biopharmaceutical Consumption by Regions

    • 5.1 Global Automation in Biopharmaceutical Consumption by Regions
      • 5.1.1 Global Automation in Biopharmaceutical Consumption by Regions
      • 5.1.2 Global Automation in Biopharmaceutical Consumption Market Share by Regions
    • 5.2 North America
      • 5.2.1 North America Automation in Biopharmaceutical Consumption by Application
      • 5.2.2 North America Automation in Biopharmaceutical Consumption by Countries
      • 5.2.3 United States
      • 5.2.4 Canada
      • 5.2.5 Mexico
    • 5.3 Europe
      • 5.3.1 Europe Automation in Biopharmaceutical Consumption by Application
      • 5.3.2 Europe Automation in Biopharmaceutical Consumption by Countries
      • 5.3.3 Germany
      • 5.3.4 France
      • 5.3.5 UK
      • 5.3.6 Italy
      • 5.3.7 Russia
    • 5.4 Asia Pacific
      • 5.4.1 Asia Pacific Automation in Biopharmaceutical Consumption by Application
      • 5.4.2 Asia Pacific Automation in Biopharmaceutical Consumption by Countries
      • 5.4.3 China
      • 5.4.4 Japan
      • 5.4.5 South Korea
      • 5.4.6 India
      • 5.4.7 Australia
      • 5.4.8 Indonesia
      • 5.4.9 Thailand
      • 5.4.10 Malaysia
      • 5.4.11 Philippines
      • 5.4.12 Vietnam
    • 5.5 Central & South America
      • 5.5.1 Central & South America Automation in Biopharmaceutical Consumption by Application
      • 5.5.2 Central & South America Automation in Biopharmaceutical Consumption by Country
      • 5.5.3 Brazil
    • 5.6 Middle East and Africa
      • 5.6.1 Middle East and Africa Automation in Biopharmaceutical Consumption by Application
      • 5.6.2 Middle East and Africa Automation in Biopharmaceutical Consumption by Countries
      • 5.6.3 GCC Countries
      • 5.6.4 Egypt
      • 5.6.5 South Africa

    6 Market Size by Type

    • 6.1 Global Automation in Biopharmaceutical Production by Type
    • 6.2 Global Automation in Biopharmaceutical Revenue by Type
    • 6.3 Automation in Biopharmaceutical Price by Type

    7 Market Size by Application

    • 7.1 Overview
    • 7.2 Global Automation in Biopharmaceutical Breakdown Dada by Application
      • 7.2.1 Global Automation in Biopharmaceutical Consumption by Application
      • 7.2.2 Global Automation in Biopharmaceutical Consumption Market Share by Application (2014-2019)

    8 Key Industry Players

    • 8.1 Danaher
      • 8.1.1 Danaher Company Details
      • 8.1.2 Production and Revenue of Automation in Biopharmaceutical
      • 8.1.3 Danaher Automation in Biopharmaceutical Product Description
      • 8.1.4 SWOT Analysis
      • 8.1.5 Danaher Economic Activity & Plans
    • 8.2 GE
      • 8.2.1 GE Company Details
      • 8.2.2 Production and Revenue of Automation in Biopharmaceutical
      • 8.2.3 GE Automation in Biopharmaceutical Product Description
      • 8.2.4 SWOT Analysis
      • 8.2.5 GE Economic Activity & Plans
    • 8.3 PerkinElmer
      • 8.3.1 PerkinElmer Company Details
      • 8.3.2 Production and Revenue of Automation in Biopharmaceutical
      • 8.3.3 PerkinElmer Automation in Biopharmaceutical Product Description
      • 8.3.4 SWOT Analysis
      • 8.3.5 PerkinElmer Economic Activity & Plans
    • 8.4 Tecan Trading
      • 8.4.1 Tecan Trading Company Details
      • 8.4.2 Production and Revenue of Automation in Biopharmaceutical
      • 8.4.3 Tecan Trading Automation in Biopharmaceutical Product Description
      • 8.4.4 SWOT Analysis
      • 8.4.5 Tecan Trading Economic Activity & Plans
    • 8.5 Thermo Fisher Scientific
      • 8.5.1 Thermo Fisher Scientific Company Details
      • 8.5.2 Production and Revenue of Automation in Biopharmaceutical
      • 8.5.3 Thermo Fisher Scientific Automation in Biopharmaceutical Product Description
      • 8.5.4 SWOT Analysis
      • 8.5.5 Thermo Fisher Scientific Economic Activity & Plans
    • 8.6 Bruker
      • 8.6.1 Bruker Company Details
      • 8.6.2 Production and Revenue of Automation in Biopharmaceutical
      • 8.6.3 Bruker Automation in Biopharmaceutical Product Description
      • 8.6.4 SWOT Analysis
      • 8.6.5 Bruker Economic Activity & Plans
    • 8.7 Peak Analysis & Automation
      • 8.7.1 Peak Analysis & Automation Company Details
      • 8.7.2 Production and Revenue of Automation in Biopharmaceutical
      • 8.7.3 Peak Analysis & Automation Automation in Biopharmaceutical Product Description
      • 8.7.4 SWOT Analysis
      • 8.7.5 Peak Analysis & Automation Economic Activity & Plans
    • 8.8 Waters
      • 8.8.1 Waters Company Details
      • 8.8.2 Production and Revenue of Automation in Biopharmaceutical
      • 8.8.3 Waters Automation in Biopharmaceutical Product Description
      • 8.8.4 SWOT Analysis
      • 8.8.5 Waters Economic Activity & Plans
    • 8.9 Capsugel
      • 8.9.1 Capsugel Company Details
      • 8.9.2 Production and Revenue of Automation in Biopharmaceutical
      • 8.9.3 Capsugel Automation in Biopharmaceutical Product Description
      • 8.9.4 SWOT Analysis
      • 8.9.5 Capsugel Economic Activity & Plans
    • 8.10 RheoSense
      • 8.10.1 RheoSense Company Details
      • 8.10.2 Production and Revenue of Automation in Biopharmaceutical
      • 8.10.3 RheoSense Automation in Biopharmaceutical Product Description
      • 8.10.4 SWOT Analysis
      • 8.10.5 RheoSense Economic Activity & Plans
    • 8.11 Eirechrom
    • 8.12 BioProcess International
    • 8.13 Novasep

    9 Entry Strategy for Key Countries

    • 9.1 Entry Strategy for United States Market
    • 9.2 Entry Strategy for China Market
    • 9.3 Entry Strategy for India Market

    10 Production Forecasts

    • 10.1 Automation in Biopharmaceutical Production and Revenue Forecast
      • 10.1.1 Global Automation in Biopharmaceutical Production Forecast 2019-2025
      • 10.1.2 Global Automation in Biopharmaceutical Revenue Forecast 2019-2025
    • 10.2 Automation in Biopharmaceutical Production and Revenue Forecast by Regions
      • 10.2.1 Global Automation in Biopharmaceutical Revenue Forecast by Regions
      • 10.2.2 Global Automation in Biopharmaceutical Production Forecast by Regions
    • 10.3 Automation in Biopharmaceutical Key Producers Forecast
      • 10.3.1 United States
      • 10.3.2 Europe
      • 10.3.3 China
      • 10.3.4 Japan
      • 10.3.5 South Korea
      • 10.3.6 India
    • 10.4 Forecast by Type
      • 10.4.1 Global Automation in Biopharmaceutical Production Forecast by Type
      • 10.4.2 Global Automation in Biopharmaceutical Revenue Forecast by Type

    11 Consumption Forecast

    • 11.1 Automation in Biopharmaceutical Consumption Forecast by Application
    • 11.2 Automation in Biopharmaceutical Consumption Forecast by Regions
    • 11.3 North America Market Consumption Forecast
      • 11.3.1 North America Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
      • 11.3.2 United States
      • 11.3.3 Canada
      • 11.3.4 Mexico
    • 11.4 Europe Market Consumption Forecast
      • 11.4.1 Europe Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
      • 11.4.2 Germany
      • 11.4.3 France
      • 11.4.4 UK
      • 11.4.5 Italy
      • 11.4.6 Russia
    • 11.5 Asia Pacific Market Consumption Forecast
      • 11.5.1 Asia Pacific Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
      • 11.5.2 China
      • 11.5.3 Japan
      • 11.5.4 South Korea
      • 11.5.5 India
      • 11.5.6 Australia
      • 11.5.7 Indonesia
      • 11.5.8 Thailand
      • 11.5.9 Malaysia
      • 11.5.10 Philippines
      • 11.5.11 Vietnam
    • 11.6 Central & South America Market Consumption Forecast
      • 11.6.1 Central & South America Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
      • 11.6.2 Brazil
    • 11.7 Middle East and Africa Market Consumption Forecast
      • 11.7.1 Middle East and Africa Automation in Biopharmaceutical Consumption Forecast by Regions 2019-2025
      • 11.7.2 GCC Countries
      • 11.7.3 Egypt
      • 11.7.4 South Africa

    12 Opportunities & Challenges, Threat and Affecting Factors

    • 12.1 Market Opportunities
    • 12.2 Market Challenges
    • 12.3 Porter's Five Forces Analysis

    13 Key Findings in the Global Automation in Biopharmaceutical Study

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in biopharmaceutical drug development facilities. The global automation market in biopharmaceutical industry includes deployment of automation in biopharmaceutical academic research centers, manufacturing and research companies, clinical labs, and government approved labs.
      One trend in the market is continuous manufacturing. Advantages of continuous operations are well-recognized in various industries. It completes the process in a shorter time as it omits the hold steps, reduces shut down time, and reduces the labor requirement. Over the decades, upstream processing utilized this technology.”
      According to the report, one driver in the market is use of automation in data acquisition. Traditionally, research labs collect data manually and store it in spreadsheets. This method is not only time-consuming but also affects operational efficiency and is prone to errors. It also restricts monitoring of data in real time. The biopharmaceutical industry is working on data collection and adding the information from spreadsheets to a database. Database collection of upstream and downstream processes is being utilized to create a library that increases operational efficiency and process optimization.
      Further, the report states that one challenge in the market is high R&D cost. The biopharmaceutical industry is a rapidly growing industry in pharmaceuticals. Complex drugs are manufactured with the help of 3-D modeling and are produced with high efficacy and precision. These drugs can provide medication to medical issues that were once incurable. Currently, the biopharmaceutical industry is looking to yield new products to address diseases such as cancer, Alzheimer's disease, and hepatitis C. Innovations in the biopharmaceutical industry are highly expensive. The average cost associated with a new drug is around $2 billion, including the cost of unsuccessful drug approvals, out of which almost $400 million is the cost included in pre-clinical and clinical testing.
      Global Automation in Biopharmaceutical market size will reach 1590 million US$ by 2025, from 1040 million US$ in 2018, at a CAGR of 6.2% during the forecast period. In this study, 2018 has been considered as the base year and 2019-2025 as the forecast period to estimate the market size for Automation in Biopharmaceutical.

      This industry study presents the global Automation in Biopharmaceutical market size, historical breakdown data (2014-2019) and forecast (2019-2025). The Automation in Biopharmaceutical production, revenue and market share by manufacturers, key regions and type;
      The consumption of Automation in Biopharmaceutical in volume terms are also provided for major countries (or regions), and for each application and product at the global level. Market share, growth rate, and competitive factors are also evaluated for market leaders Danaher, GE, etc.

      The following manufacturers are covered in this report:
      Danaher
      GE
      PerkinElmer
      Tecan Trading
      Thermo Fisher Scientific
      Bruker
      Peak Analysis & Automation
      Waters
      Capsugel
      RheoSense
      Eirechrom
      BioProcess International
      Novasep

      Automation in Biopharmaceutical Breakdown Data by Type
      Clinical stage automation
      Drug discovery stage automation
      Automation in Biopharmaceutical Breakdown Data by Application
      Research and Development
      Clinical

      Automation in Biopharmaceutical Production by Region
      United States
      Europe
      China
      Japan
      South Korea
      India
      Other Regions

      Automation in Biopharmaceutical Consumption by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Rest of Europe
      Central & South America
      Brazil
      Rest of South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa
      Rest of Middle East & Africa

      The study objectives are:
      To analyze and research the global Automation in Biopharmaceutical status and future forecast,involving, production, revenue, consumption, historical and forecast.
      To present the key Automation in Biopharmaceutical manufacturers, production, revenue, market share, SWOT analysis and development plans in next few years.
      To segment the breakdown data by regions, type, manufacturers and applications.
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions.
      To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Automation in Biopharmaceutical :
      History Year: 2014 - 2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year: 2019 - 2025

      This report includes the estimation of market size for value (million USD) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Automation in Biopharmaceutical market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Automation in Biopharmaceutical . Industry analysis & Market Report on Automation in Biopharmaceutical is a syndicated market report, published as Global Automation in Biopharmaceutical Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Automation in Biopharmaceutical market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,900.00
      $7,350.00
      $9,800.00
      3,921.44
      5,882.15
      7,842.87
      4,441.05
      6,661.57
      8,882.09
      528,626.70
      792,940.05
      1,057,253.40
      348,310.62
      522,465.93
      696,621.24
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report